Cargando…

CRISPR interference provides increased cell type-specificity compared to the Cre-loxP system

Cre-mediated recombination is frequently used for cell type-specific loss of function (LOF) studies. A major limitation of this system is recombination in unwanted cell types. CRISPR interference (CRISPRi) has been used effectively for global LOF in mice. However, cell type-specific CRISPRi, indepen...

Descripción completa

Detalles Bibliográficos
Autores principales: Laster, Dominique J., Akel, Nisreen S., Hendrixson, James A., James, Alicen, Crawford, Julie A., Fu, Qiang, Berryhill, Stuart B., Thostenson, Jeff D., Nookaew, Intawat, O’Brien, Charles A., Onal, Melda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10415806/
https://www.ncbi.nlm.nih.gov/pubmed/37575184
http://dx.doi.org/10.1016/j.isci.2023.107428
Descripción
Sumario:Cre-mediated recombination is frequently used for cell type-specific loss of function (LOF) studies. A major limitation of this system is recombination in unwanted cell types. CRISPR interference (CRISPRi) has been used effectively for global LOF in mice. However, cell type-specific CRISPRi, independent of recombination-based systems, has not been reported. To test the feasibility of cell type-specific CRISPRi, we produced two novel knock-in mouse models that achieve gene suppression when used together: one expressing dCas9::KRAB under the control of a cell type-specific promoter and the other expressing a single guide RNA from a safe harbor locus. We then compared the phenotypes of mice in which the same gene was targeted by either CRISPRi or the Cre-loxP system, with cell specificity conferred by Dmp1 regulatory elements in both cases. We demonstrate that CRISPRi is effective for cell type-specific LOF and that it provides improved cell type-specificity compared to the Cre-loxP system.